MILLENDO THERAPEUTICS INC's ticker is MLND and the CUSIP is 60040X103. A total of 47 filers reported holding MILLENDO THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $25,000 | -72.5% | 20,883 | -50.9% | 0.00% | – |
| Q4 2020 | $91,000 | -30.0% | 42,532 | -46.8% | 0.00% | – |
| Q3 2020 | $130,000 | -34.3% | 79,964 | -28.9% | 0.00% | – |
| Q2 2020 | $198,000 | -22.4% | 112,488 | +132.5% | 0.00% | – |
| Q1 2020 | $255,000 | +18.6% | 48,391 | +237.7% | 0.00% | – |
| Q1 2019 | $215,000 | – | 14,331 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 1,396,615 | $9,930,000 | 3.10% |
| NEA Management Company, LLC | 1,766,779 | $12,562,000 | 1.04% |
| Samsara BioCapital, LLC | 186,540 | $1,326,000 | 0.90% |
| GREAT POINT PARTNERS LLC | 1,288,093 | $9,158,000 | 0.84% |
| Bpifrance SA | 1,078,670 | $7,669,000 | 0.83% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 177,825 | $1,264,000 | 0.58% |
| ADAMS STREET PARTNERS LLC | 367,935 | $2,616,000 | 0.52% |
| Prosight Management, LP | 52,051 | $370,000 | 0.20% |
| GMT CAPITAL CORP | 53,419 | $380,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 38,881 | $276,000 | 0.00% |